薬剤注入システム市場：製品タイプ、用途、エンドユーザー別-2024～2030年の世界予測

薬剤注入システム市場規模は、2023年に226億1,000万米ドルと推定され、2024年には240億1,000万米ドルに達し、CAGR 6.67%で2030年には355億5,000万米ドルに達すると予測されています。

薬剤注入システムは、制御された方法で患者の体内に薬剤を送達するように設計された高度な医療機器です。これらのシステムは、薬剤が適切な速度、量、時間で投与され、意図した治療効果が得られるように設計されています。薬剤注入システムは、連続注入ポンプ、PCA（patient-controlled analgesia）ポンプ、エラストマーポンプ、シリンジポンプなど、その機能性により様々なタイプに分類されます。薬剤注入システムを使用する主な利点は、化学療法、インスリン療法、疼痛管理など、高い精度が要求される治療において極めて重要な、一貫した正確な投薬量を提供する能力にあります。これらのシステムは、薬剤投与において柔軟性を提供し、患者の特定のニーズや治療に対する反応に基づいて投与スケジュールや量を調整することができます。薬剤注入システムは、患者の快適性と利便性を向上させ、手作業による頻繁な薬剤投与の必要性を減らし、長期間にわたるドラッグデリバリーの制御を可能にします。がんの罹患率の増加、化学療法用輸液ポンプの必要性、技術革新と先進的な機器の採用の増加が、薬剤注入システム市場の成長を促進しています。しかし、サイバー脅威が高まる中で輸液システムの安全性と有効性を確保することは課題です。ドラッグデリバリー技術における個別化医療のためのIoTとAIの統合の広がりと、ヘルスケアインフラの改善への投資の増加は、市場浸透の広大な展望を提供します。

製品タイプ慢性疾患に対する懸念の高まりにより、輸液用ディスポーザブルの使用が増加

輸液ポンプは、栄養剤や薬剤を含む輸液を患者の体内に制御された量だけ送り込むために設計された高度な医療機器です。これらのポンプには、外来用、据え置き型、シリンジ型、容量ポンプなどさまざまな形態があり、それぞれが特定の患者のニーズに合わせて調整されています。輸液ポンプは、病院環境と在宅ケアの両方で不可欠であり、投与速度と投与量を正確に制御し、化学療法から疼痛管理まで幅広い治療に対応します。エラー検出のための輸液ポンプのプログラム性とアラームは、患者の安全性と治療効果を高めます。輸液用ディスポーザブルは、静脈内治療における単回使用を目的とした幅広いカテゴリーの製品を包含します。このカテゴリーには、カテーテル、チューブ、針、輸液バッグなどが含まれます。IVディスポーザブルは、感染リスクを最小限に抑え、無菌性を確保するように設計されており、患者の血流に直接薬剤、輸液、栄養分を投与する上で極めて重要です。救急治療室から長期介護施設まで、多くの医療現場で極めて重要な役割を果たし、救命治療のための無菌経路を提供しています。便利で安全な点滴用ディスポーザブルは、現代のヘルスケアに欠かせないものとなっています。

用途最適な血糖値を維持し、糖尿病関連合併症を最小限に抑えるために薬剤注入システムを多用

薬剤注入システムは、インスリンポンプ療法による糖尿病、特に1型糖尿病の管理において、極めて重要な役割を果たしています。これらのデバイスは、健康な膵臓からのインスリン分泌を模倣して、短時間作用型または速効型インスリンを1日中持続的に投与します。この方法は、グルコースモニタリングデータに応じてインスリンレベルをより正確に調整し、高血糖と低血糖のリスクを低減することにより、血糖コントロールと生活の質を改善することができます。クローン病や潰瘍性大腸炎などの慢性消化器疾患の管理では、生物学的療法を血流に直接投与するために薬剤注入システムが利用されています。このような輸液療法は、標準的な治療に反応しない患者にとってより効果的です。さらに、ドラッグデリバリーをコントロールすることで、全身投与に伴う副作用を最小限に抑えることができます。薬剤注入システムは、腫瘍学において化学療法デリバリーにおいて非常に重要であり、ドラッグデリバリーの速度とタイミングを正確にコントロールすることができ、副作用を最小限に抑えながら治療効果を高めることができます。薬剤注入システムは、薬剤を長期にわたって投与する持続点滴化学療法に使用することができ、ある種のがんにはより効果的です。さらに、がん治療への個別化されたアプローチを可能にし、患者固有の薬物レジメンや投与量に対応することができます。小児科領域では、薬剤注入システムは、小児特有の要件に適した制御された正確なドラッグデリバリーを提供することにより、大きな利点を提供します。感染症の抗生物質投与からがん治療の化学療法まで、さまざまな場面で使用されています。薬剤注入システムの精度は、体重に基づいて投与量を慎重に計算しなければならないことが多い小児集団にとって極めて重要です。

地域別の洞察

南北アメリカ、特に米国とカナダでは、糖尿病やがんなどの慢性疾患の蔓延により、高度な薬剤注入システムに対する需要が高いです。米国市場は、高いヘルスケア支出と先進的なヘルスケアソリューションに重点を置いていることが特徴であり、スマートでコネクテッドなポータブル輸液デバイスが好まれています。カナダには、先進医療機器を支援するヘルスケア構想があります。アジア太平洋地域は多様性に富んでおり、経済格差やヘルスケア・アクセスの影響を受け、消費者のニーズは基本的なものから高度な輸液システムまで多岐にわたる。中国市場は、医療改革を推進する政府のイニシアチブ、ヘルスケア・インフラへの投資、中産階級の消費者層の拡大により活況を呈しています。日本は、ヘルスケアを中心に、さまざまな分野で技術的進歩を示しています。日本の薬剤注入システムに対するアプローチは革新性と使いやすさを重視しており、高齢化社会と、臨床現場と自宅の両方で管理できる効率的なヘルスケアソリューションの必要性がその原動力となっています。インドの薬剤注入システム市場は、医療費の増加と意識の向上により成長しています。MEA地域は、ヘルスケア・インフラとアクセス・レベルが異なる多様な市場です。湾岸協力会議（GCC）諸国では、病院や診療所での先進的な薬剤注入システムの採用など、ヘルスケアへの大規模な投資が行われています。アフリカ地域では、ヘルスケアの改善を目指した取り組みや国際機関との提携により、市場の潜在力が徐々に高まっています。EU諸国では、有利な医療政策、高齢者人口の増加、慢性疾患の増加を背景に、薬剤注入システムの導入が拡大しています。EUには医療機器に関する厳しい規制があり、高い品質と安全基準が確保されています。最近の投資は、患者の移動性と快適性を促進するスマート輸液システムの開発に向けられています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは薬剤注入システム市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、薬剤注入システム市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.薬剤注入システム市場の市場規模および予測は？

2.薬剤注入システム市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.薬剤注入システム市場の技術動向と規制枠組みは？

4.薬剤注入システム市場における主要ベンダーの市場シェアは？

5.薬剤注入システム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんの発生率増加と化学療法輸液ポンプの必要性
    • 輸液ポンプの導入増加
    • 効率的かつ正確なドラッグデリバリーシステムに対する需要の高まりと在宅ヘルスケアへの移行
  • 抑制要因
    • 調達と設置の初期コストが高い
  • 機会
    • ドラッグデリバリー技術における個別化医療のためのIoTとAIの統合の拡大
    • 薬剤注入システムへの投資と研究開発の増加
  • 課題
    • サイバー脅威が高まる中、輸液システムの安全性と有効性を確保する
• 市場セグメンテーション分析
  • 製品タイプ：慢性疾患に関する継続的な懸念により、IVディスポーザブルの使用が増加しています。
  • 応用：最適な血糖値を維持し、糖尿病関連の合併症を最小限に抑えるために薬剤注入システムを多用する
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 薬剤注入システム市場：製品タイプ別

• 輸液ポンプ
• IVディスポーザブル

第7章 薬剤注入システム市場：用途別

• 糖尿病
• 消化器疾患
• 腫瘍学
• 小児科

第8章 薬剤注入システム市場：エンドユーザー別

• ホームケア
• 病院
• 専門クリニック

第9章 南北アメリカの薬剤注入システム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の薬剤注入システム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬剤注入システム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • フレゼニウス・カビとメイヨー・クリニックがイベニックス輸液システムで契約を締結
  • インシュレット、調整可能なアラーム制限とボーラス漏れアラームを備えた輸液ポンプシステムの特許を申請
  • エイタン・メディカル、クラウドベースの輸液管理プラットフォームを発表
• 戦略分析と提言

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. DRUG INFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. DRUG INFUSION SYSTEMS MARKET DYNAMICS
• FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 52. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 53. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 56. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 86. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 87. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 90. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 91. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 92. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 93. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 196. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 197. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 219. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 220. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 221. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 226. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 227. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 230. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 285. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

[181 Pages Report] The Drug Infusion Systems Market size was estimated at USD 22.61 billion in 2023 and expected to reach USD 24.01 billion in 2024, at a CAGR 6.67% to reach USD 35.55 billion by 2030.

Drug infusion systems are sophisticated medical devices designed to deliver drugs into a patient's body in a controlled manner. These systems are engineered to ensure that medications are administered at the proper rate, volume, and duration to achieve the intended therapeutic effect. Drug infusion systems can be classified into various types based on their functionality, including continuous infusion pumps, patient-controlled analgesia (PCA) pumps, elastomeric pumps, and syringe pumps. The core advantage of using drug infusion systems lies in their ability to provide a consistent and precise dosage of medication, which is crucial for treatments that require a high level of accuracy, such as chemotherapy, insulin therapy, and pain management. These systems offer flexibility in drug administration, allowing for adjustments in dosing schedules and amounts based on the patient's specific needs and response to treatment. Drug infusion systems enhance patient comfort and convenience, reducing the need for frequent manual drug administration and enabling controlled drug delivery over extended periods. The growing incidence of cancer, the need for chemotherapy infusion pumps, and the increasing innovation and adoption of technologically advanced devices are driving the growth of the drug infusion systems market. However, ensuring the safety and efficacy of infusion systems amid rising cyber threats is challenging. The widening integration of IoT and AI for personalized medicine in drug delivery technologies and increasing investments in improving healthcare infrastructures offer vast prospects for market penetration.

Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases

The infusion pumps are sophisticated medical devices designed for delivering fluids, including nutrients and medications, into a patient's body in controlled amounts. These pumps come in various forms, including ambulatory, stationary, syringe, and volumetric pumps, each tailored to specific patient needs. Infusion pumps are essential in both hospital settings and home care and offer precise control over the delivery rates and volume, accommodating a wide range of therapies, from chemotherapy to pain management. The programmability and alarms of infusion pumps for error detection enhance patient safety and treatment efficacy. IV disposables encompass a broad category of products intended for single use in intravenous therapy. This category includes catheters, tubing, needles, and IV bags. IV disposables are designed to minimize the risk of infection and ensure sterility and are crucial in administering drugs, fluids, and nutrients directly into a patient's bloodstream. They are pivotal in many medical settings, ranging from emergency rooms to long-term care facilities, providing a sterile pathway for administering life-saving treatments. The convenience and safety aspects of IV disposables make them indispensable in modern healthcare.

Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications

Drug infusion systems play a pivotal role in the management of diabetes, particularly Type 1 diabetes, through insulin pump therapy. These devices continuously deliver short-acting or rapid-acting insulin throughout the day, mimicking how a healthy pancreas releases insulin. This method can improve glycemic control and quality of life by allowing more precise adjustment of insulin levels in response to glucose monitoring data, reducing both hyperglycemia and the risk of hypoglycemia. In managing chronic gastrointestinal diseases such as Crohn's disease or ulcerative colitis, drug infusion systems are utilized to administer biological therapies directly into the bloodstream. These infusion therapies are more effective for the ones who do not respond to standard treatment. Additionally, the controlled delivery of drugs can minimize side effects associated with systemic administration. Drug infusion systems are critically important in oncology for chemotherapy delivery and enable precise control over the rate and timing of drug delivery, which can enhance the efficacy of the treatment while minimizing its side effects. Drug infusion systems can be used for continuous infusion chemotherapy, where drugs are administered over a long period, which may be more effective for certain types of cancer. Furthermore, they allow for a more personalized approach to cancer treatment, accommodating patient-specific drug regimens and dosages. In pediatrics, drug infusion systems offer significant advantages by providing controlled and accurate drug delivery suitable for children's unique requirements. They are used in various scenarios, from antibiotic administration for infections to chemotherapy for cancer treatment. The precision of drug infusion systems is crucial for the pediatric population, where dosages often must be carefully calculated based on weight.

Regional Insights

In the Americas, particularly the United States and Canada, there is a high demand for advanced drug infusion systems due to the prevalence of chronic diseases, including diabetes and cancer. The U.S. market is characterized by high healthcare spending and a strong emphasis on advanced healthcare solutions, leading to a preference for smart, connected, and portable infusion devices. Canada has healthcare initiatives supporting advanced medical devices. The Asia Pacific region is diverse, with consumer needs ranging from basic to advanced infusion systems, influenced by economic disparities and healthcare access. China's market is booming due to government initiatives promoting healthcare reform, investment in healthcare infrastructure, and a growing middle-class consumer base. Japan showcases technological advancements across various sectors, with healthcare being a prime focus. Japan's approach to drug infusion systems emphasizes innovation and user-friendliness and is driven by an aging population and the necessity for efficient healthcare solutions that can be managed both in clinical settings and at home. India's drug infusion systems market is growing with increasing healthcare spending and awareness. The MEA region presents a diverse market with varying healthcare infrastructure and access levels. The Gulf Cooperation Council (GCC) countries are witnessing significant investments in healthcare, including the adoption of advanced drug infusion systems in hospitals and clinics. In the African region, initiatives aimed at healthcare improvement and partnerships with international organizations are gradually enhancing the market potential in these regions.EU countries exhibit a growing adoption of drug infusion systems, driven by favorable healthcare policies, an increase in the geriatric population, and a rise in chronic conditions. The EU has stringent regulations regarding medical devices, ensuring high quality and safety standards. Recent investments have been channeled toward developing smart infusion systems that promote patient mobility and comfort.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Infusion Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Infusion Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Infusion Systems Market, highlighting leading vendors and their innovative profiles. These include AKAS Infusions, B. Braun SE, Baxter International, Inc., Becton, Dickinson, and Company, Debiotech S.A., Eitan Medical, Flowonix Medical Inc., Fresenius Kabi AG, Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., Insulet Corporation, Intera Oncology Inc., IRADIMED CORPORATION, Ivenix Inc., Medtronic Plc, Micrel Medical Devices SA, Microport Scientific Corporation, MOOG, Inc., Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Infusion Pump
  • IV Disposable

• Application
  • Diabetes
  • Gastrointestinal Diseases
  • Oncology
  • Pediatrics

• End-user
  • Homecare
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Infusion Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Infusion Systems Market?

3. What are the technology trends and regulatory frameworks in the Drug Infusion Systems Market?

4. What is the market share of the leading vendors in the Drug Infusion Systems Market?

5. Which modes and strategic moves are suitable for entering the Drug Infusion Systems Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of cancer and the need for chemotherapy infusion pumps
    • 5.1.1.2. Increasing adoption of infusion pumps
    • 5.1.1.3. Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. High initial cost of procurement and installation
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing integration of IoT and AI for personalized medicine in drug delivery technologies
    • 5.1.3.2. Increasing investments and R&D in drug infusion system
  • 5.1.4. Challenges
    • 5.1.4.1. Ensuring safety and efficacy of infusion systems amid rising cyber threats
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases
  • 5.2.2. Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Drug Infusion Systems Market, by Product Type

• 6.1. Introduction
• 6.2. Infusion Pump
• 6.3. IV Disposable

7. Drug Infusion Systems Market, by Application

• 7.1. Introduction
• 7.2. Diabetes
• 7.3. Gastrointestinal Diseases
• 7.4. Oncology
• 7.5. Pediatrics

8. Drug Infusion Systems Market, by End-user

• 8.1. Introduction
• 8.2. Homecare
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Drug Infusion Systems Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Infusion Systems Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Infusion Systems Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Fresenius Kabi, Mayo Clinic Ink Deal On Ivenix Infusion System
  • 12.3.2. Insulet Files Patent On Infusion Pump System With Adjustable Alarm Limits And Missed Bolus Alarm
  • 12.3.3. Eitan Medical Launched Cloud-Based Infusion Management Platform
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio